Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 16/20 | 0.78 |
| ▸ | HTR1B | P28222 | 12/20 | 0.68 |
| ▸ | HTR1A | P08908 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7434651 | 0.90 | HTR1D (0.83) | HTR1DHTR1BDRD2 | |
| SCHEMBL8316283 | 0.88 | HTR1D (1.00) | HTR1DHTR1BHTR1ADRD2 | |
| SCHEMBL8315482 | 0.81 | HTR1D (1.00) | HTR1DHTR1B | |
| SCHEMBL7447504 | 0.81 | HTR1D (0.84) | HTR1DHTR1BDRD2 | |
| SCHEMBL7441015 | 0.81 | HTR1D (0.69) | HTR1DHTR1BHTR1ADRD2 | |
| SCHEMBL7436234 | 0.81 | HTR1D (0.86) | HTR1DHTR1BDRD2 | |
| SCHEMBL7442744 | 0.78 | HTR1D (0.81) | HTR1DHTR1B | |
| SCHEMBL7439303 | 0.77 | HTR1D (0.87) | HTR1DHTR1BHTR1ADRD2 | |
| SCHEMBL8315256 | 0.75 | HTR1D (1.00) | HTR1DHTR1B | |
| SCHEMBL8316440 | 0.74 | HTR1D (1.00) | HTR1DHTR1BDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5639778-A | TREATING CENTRAL NERVOUS SYSTEM DISORDERS | PHARMACIA & UPJOHN COMPANY (US) | 1997-06-17 | — | — | US | disclosed |
| EP-0690843-A1 | INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY | PHARMACIA & UPJOHN COMPANY (US) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994021608-A1 | INDOLETETRALINS HAVING DOPAMINERGIC ACTIVITY | THE UPJOHN COMPANY (US) | 1994-09-29 | — | — | WO | disclosed |